Диссертация (1140836), страница 23
Текст из файла (страница 23)
/R.C. Baxter // Metabolism. - 1995. - № 44. - Р. 12-7.86.Bornar? L.M. High prevalence of vitamin D insufficiency in black and whitepregnant women residing in the northern United States and their neonates /L.M. Bornar, H.N. Simhan, R.W. Powers, M.P. Frank, E. Cooperstein, J.M.Roberts// J Nutr. - 2007. - № 137(2). Р. 447-52.87.Bodnar, LM. Maternal serum 25-hydroxyvitamin D concentrations areassociated with small-for-gestational age births in white women / L.MBodnar, J.M. Catov, J.M. Zmuda, M.E.
Cooper, M.S. Parrott, J.M. Roberts,M.L. Marazita, H.N. Simhan // J Nutr. - 2010. - № 140. - Р. 999–1006.88.Bower, S. Doppler ultrasound screening as part of routine antenatalscanning: prediction of pre-eclampsia and intrauterine growth retardation. /S. Bower // Br J Obstet Gynaecol. - 1993. - № 100. - Р. 989–994.89.Breathnach, F.M. First- and second-trimester screening. / F.M Breathnach,F.D. Malone, G. Lambert-Messerlian // Obstet Gynecol.
- 2007. - № 110. Р. 651.14590.Bukowski, R. Stillbirth and fetal growth restriction / Bukowski R. // ClinObstet Gynecol. - 2010. - № 53. - Р. 673–680.91.Bustamante-Aragones A. Prenatal diagnosis of Huntington disease inmaternal plasma: direct and indirect study / Bustamante-Aragones A,Trujillo-Tiebas MJ, Gallego-Merlo J, Rodriguez de Alba M, GonzalezGonzalez C, Cantalapiedra D. // Eur J Neurol. - 2008. - № 15. - Р. 1338-4492.Campbell, S. New doppler technique for assessing uteroplacental bloodflow.
/ S. Campbell// Lancet. - 1983. - № 1. - Р. 675–677.93.Campbell, S. Qualitative assessment of uteroplacental blood flow: earlyscreening test for high-risk pregnancies. / S. Campbell //Obstet Gynecol. 1986. - № 68. - Р. 649–653.94.Carrera J.M. Intrauterine growth restriction // VIII World Congress ofGynecology and Obstetrics (FIGO), Mexico, 1976/.95.Chafetz, I. First-trimester placental protein 13 screening for preeclampsiaand intrauterine growth restriction.
/ I. Chafetz //Am J Obstet Gynecol. 2007. - № 197. - Р. 1–7.96.Conde-Agudelo, A. Novel biomarkers for predicting intrauterine growthrestriction: a systematic review and meta-analysis. / A. Conde-Agudelo //BJOG. - 2013. - № 120. - Р. 681–694.97.Conde-Agudelo, A.
World Health Organization systematic review ofscreening tests for preeclampsia. / A.Conde-Agudelo //Obstet Gynecol. 2004. - № 104. - Р. 1367–1391.98.Cowans, N.J. First-trimester ADAM12 and PAPP-A as markers forintrauterine fetal growth restriction through their roles in the insulin-likegrowth factor system. / N.J. Cowans // Prenat Diagn. - 2007.
- № 27. - Р.264–271.99.Cowans, N.J. First-trimester maternal placental protein 13 levels inpregnancies resulting in adverse outcomes. / N.J. Cowans // Prenat Diagn. 2008. - № 28. - Р. 121–125.100.Creasy Robert K., Resnik R., Iams J.D. Maternal-fetal medicine.Principles and Practice. PA.:Elsevier Saunders. - 2014.101.Cunningham F., Leveno K., Bloom S., Hauth J., Rouse D., Spong C.Diseases and injuries of the fetus and newborn.
In:Williams Obstetrics. 23 rdedition. McGraw Hill Professional Publishing. – 2010. – РР.604-646.102.De Jong C.L. Customized fetal weight limits for antenatal detection offetal growth restriction. / C.L. De Jong // Ultrasound Obstet Gynecol. 2000. - № 15. - Р. 36–40.103.De Leon J.S.G. Maternal serum free β-hCG levels in uncomplicatedpregnancies at the 10th-15th week of gestation and the development of146obstetric complications. / J.S.G. De Leon // J Reprod Med. - 2009. - № 49. Р. 89–92.104.De-Regil, L.M. Vitamin D supplementation for women duringpregnancy / L.M.
De-Regil, C. Palacios, L.K. Lombardo // Sao Paulo Med J.- 2016. - № 3. - P. 274–275.105.Dugoff, L. First trimester uterine artery Doppler abnormalities predictsubsequent intrauterine growth restriction. / L. Dugoff // Am J ObstetGynecol. - 2005. - № 193. - Р. 1208–1212.106.Dugoff, L. First-trimester maternal serum PAPP-A and free-betasubunit human chorionic gonadotropin concentrations and nuchaltranslucency are associated with obstetric complications: a population-basedscreening study (the FASTER Trial) / L.
Dugoff // Am J Obstet Gynecol. 2004. - № 191. - Р. 1446–1451.107.Evans, K.N. Vitamin D and placental-decidual function / K.N. Evans,J.N. Bulmer, M.D. Kilby, M. Hewison // J. Soc. Gynecol. Investig. - 2004. № 11. - P. 263-271.108.Farag, K. Prediction of preeclampsia: can it be achieved? / K. Farag //Obstet Gynecol Surv. - 2004. - № 59.
- Р. 464–482.109.Figueras, F. Intrauterine growth restriction: new concepts in antenatalsurveillance, diagnosis, and management / F. Figueras // Am J ObstetGynecol. - 2011. - № 204. - Р. 288–300.110.Figueras, F. Should we customize fetal growth standards? / F.Figueras // Fetal Diagn Ther. - 2009. - № 25. - Р. 297–303.111.Fowden, A. Intrauterine programming of physiological systems:causes and consequences / A. Fowden, D. Giussani, A. Forhead //Physiology. - 2006. - № 21. - Р.
29-37.112.Gagnon, A. Society of Obstetricians and Gynaecologists of CanadaGenetics Committee. Obstetrical complications associated with abnormalmaternal serum markers analytes / A. Gagnon // J Obstet Gynaecol Can. 2008. - № 30. - Р. 918–949.113.Gardosi, J. Classification of stillbirth by relevant condition at death(ReCoDe): population based cohort study. / J. Gardosi //BMJ.
- 2005. - №12. - Р. 1113–1117.114.Gardosi, J. Customised assessment of fetal growth potential:implications for perinatal care. / J. Gardosi // Arch Dis Child Fetal Neonatal. - 2012. - № 97. - Р. 314–317.115.Gardosi J. Intrauterine growth restriction: new standards for assessingadverse outcome. / J. Gardosi // Best Pract Res Clin Obstet Gynaecol. 2009. - № 23. - Р. 741–749.147116.Gardosi J. Maternal and fetal risk factors for stillbirth: populationbased study. / J. Gardosi // BMJ. - 2013. - № 24117.Gardosi, J. The value of customised centiles in assessing perinatalmortality risk associated with parity and maternal size.
/ J. Gardosi // BJOG.- 2009. - № 116. - Р. 1356–1363.118.Gascoin, G. Long-term outcome in context of intrauterine growthrestriction and/or small for gestational age of newborns / G. Gascoin, C.Flamant // J Obstet Gynecol Biol Reprod (Paris). - 2013. - № 42(8). – Р.911-920.119.Gebb, J.
Colour Doppler ultrasound of spiral artery blood flow in theprediction of pre-eclampsia and intrauterine growth restriction / J. Gebb //Best Pract Res Clin Obstet Gynecol. - 2011. № 25. - Р. 355–366.120.Gentili S. Intrauterine growth restriction and differential patterns ofhepatic growth and expression of IGF1, PCK2, and HSDL1 mRNA in thesheep fetus in late gestation / Gentili S, Morrison JL, McMillen IC. // BiolReprod.
- 2009. - № 80. - Р. 1121–1127121.Gluckman, P.D. The role of developmental plasticity and epigeneticsin human health. Birth Defects Res / P.D. Gluckman, M.A. Hanson, F.M.Low // C Embrio Today. - 2011. - № 93. - Р. 12-18122.Godfrey, K.M. Maternal nutrition in relation to fetal and placentalgrowth / K.M. Godfrey, D.J.
Barker // Eur. J. Obstet. Gynecol. Reprod. Biol.- 1995. - №. 61 (1). - P. 15-22.123.Goetzinger, K.R. The efficiency of first-trimester serum analytes andmaternal characteristics in predicting fetal growth disorders / K.R.Goetzinger, A. Singla, S. Gerkowicz // Am. J. Obstet. Gynecol. - 2009. - №201 (4). - Р. 22-23.124.Gómez, O. Sequential changes in uterine artery blood flow patternbetween the first and second trimesters of gestation in relation to pregnancyoutcome / O.
Gómez // Ultrasound Obstet Gynecol. - 2006. - № 28. - Р. 802–808.125.Graham, EM. A retrospective analysis of Erb's palsy cases and theirrelation to birth weight and trauma at delivery / EM. Graham // J MaternFetal Med. - 1997. - № 6. - Р. 1–5.126.GrundmannM. Vitamin D – roles in women’s reproductive health /GrundmannM.,vonVersen-HöynckF. // Reproductive Biology andEndocrinology. - 2011. - № 9 (2). - Р. 146.127.Guiot, C. Is three-dimensional power Doppler ultrasound useful in theassessment of placental perfusion in normal and growth-restricted148pregnancies? / C. Guiot // Ultrasound Obstet Gynecol.
- 2008. - № 31. - Р.171–176.128.Hafner, E. Comparison between three-dimensional placental volumeat 12 weeks and uterine artery impedance/notching at 22 weeks in screeningfor pregnancy-induced hypertension, pre-eclampsia and fetal growthrestriction in a low-risk population. / E.
Hafner // Ultrasound ObstetGynecol. - 2006. - № 27. - Р. 652–657.129.Hafner, E. Measurement of placental bed vascularization in the firsttrimester, using 3D-power-Doppler, for the detection of pregnancies at-riskfor fetal and maternal complications. / E. Hafner // Placenta. - 2013. - № 34.- Р. 892–898.130.Halloran B.P. Influence of vitamin D deficiency on fertility andreproductive ability in the female rat / Halloran B.P., Deluca H.F. // Journalof Nutrition. - 1980. - № 110 (8).
- Р. 1573-1580.131.Haram, K. Intrauterine growth restriction: effects of physiologicalfetal growth determinants on diagnosis. / K. Haram // Obstet Gynecol Int. 2013132.Harding, G.E. The nutritional basis of the fetal origins of adult disease/ G.E. Harding // International Journal of Epidemiology. - 2001. - №.30. - Р.15-23.133.Harris TG. Specimen processing time and measurement of totalinsulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3(IGFBP-3) / Harris TG, Strickler HD, Yu H. et al // Growth Horm IGF Res.- 2006. - № 16. - Р.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
